About Adaptilens
Adaptilens is a private company based in Chestnut Hill, Massachusetts, incorporated in 2024 in Delaware. It has reported $8,600,000 raised in two offerings on Form D since June 2023. Its chief executive is Liane Clamen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 24, 2024 | May 2, 2024 | $7,000,000of $16.0M target | 12 | $583K | Equity, Conversion of NotesRule 506(b) | Form D ↗ |
| Mar 28, 2023 | Jun 29, 2023 | $1,600,000fully sold | 12 | $133K | Debt, Conversion of NotesRule 506(b) | Form D ↗ |
| Total, two offerings | $8,600,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Adaptilens's Form D filed May 2, 2024.
JG
Jamie Goldstein
Director
CL
C. Gianna Luca
Director
WS
William Shea
Director
LC
Liane Clamen
Chief Executive Officer and director
Earlier filings also listed Terry Kim (director, last listed Jun 2023), Robert Doris (director, last listed Jun 2023) and John Andres (director, last listed Jun 2023).